Armata Pharmaceuticals (ARMP) Net Margin (2013 - 2020)

Armata Pharmaceuticals has disclosed Net Margin across 6 years of filings, most recently posting 15193.55% for Q2 2020.

• Net Margin for Q2 2020 came in at 15193.55%, changed N/A year-over-year; the trailing twelve-month figure through Jun 2020 was 18229.91% (changed N/A YoY), and the FY2017 annual result was 12488.7%, down 315177.0% from the prior year.
• Net Margin came in at 15193.55% for Q2 2020 at Armata Pharmaceuticals, down from 11650.0% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 2050.0% in Q3 2017 to a low of 43181.82% in Q4 2016.
• The 3-year median for Net Margin is 11650.0% (2017), against an average of 15010.05%.
• Across the five-year window, Net Margin sank 4069744 bps in 2016 and soared 3153182 bps in 2017, its largest moves.
• Armata Pharmaceuticals' Net Margin stood at 43181.82% in 2016, then soared by 73 bps to 11650.0% in 2017, then plunged by 30 bps to 15193.55% in 2020.
• The last three Net Margin figures came in at 15193.55% (Q2 2020), 11650.0% (Q4 2017), and 2050.0% (Q3 2017), per Business Quant data.